Tscan Therapeutics Inc. (TCRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 7,857,347 $11,393,153 +47% 3.29%
2. 5,226,074 $7,577,807 +7% 0.27%
3.
Baker Bros. Advisors

Julian Baker And Felix Baker

2,784,792 $4,037,948 0.04%
4.
Propel Bio Management

Leen Kawas And Richard Kayne

2,087,139 $3,026,352 3.67%
5. 792,056 $1,148,481 +367% 0%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$1.20 1,200,000 $1,440,000.00 7,946,141 2025-05-20 Filing
$1.20 1,388,794 $1,666,552.80 6,746,141 2025-05-19 Filing
$2.90 100,000 $290,140.00 5,357,347 2024-12-13 Filing
$3.01 31,800 $95,628.96 5,257,347 2024-12-12 Filing
$4.34 947 $4,113.96 5,225,547 2024-11-15 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$5.78 164,686 $952,115.64 4,716 2024-08-23 Filing
$2.51 400 $1,003.00 5,224,600 2023-05-31 Filing
$2.52 15,000 $37,801.50 5,225,000 2023-05-31 Filing
$2.51 10,000 $25,148.00 5,240,000 2023-05-31 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 2,566,524 $3,721,460 0%
2. 2,149,376 $3,116,595 0%
3. 1,245,504 $1,805,981 0.14%
4. 1,077,080 $1,561,766 0.07%
5. 1,046,916 $1,518,028 0.08%
News See All